Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study

Fenofibrate lowers triglycerides (TG) and raises high density lipoprotein cholesterol (HDLc) in dyslipidemic individuals. Several studies have shown genetic variability in lipid responses to fenofibrate treatment. It is, however, not known whether epigenetic patterns are also correlated with the cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Mithun, Irvin, M. Ryan, Sha, Jin, Aslibekyan, Stella, Hidalgo, Bertha, Perry, Rodney T., Zhi, Degui, Tiwari, Hemant K., Absher, Devin, Ordovas, Jose M., Arnett, Donna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586504/
https://www.ncbi.nlm.nih.gov/pubmed/26483836
http://dx.doi.org/10.3389/fgene.2015.00304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586504/
https://www.ncbi.nlm.nih.gov/pubmed/26483836
http://dx.doi.org/10.3389/fgene.2015.00304

Ejemplares similares